Chihara, Yusuke
Date, Koji
Takemura, Yoshizumi
Tamiya, Nobuyo
Kohno, Yoshihito
Imabayashi, Tatsuya
Kaneko, Yoshiko
Yamada, Tadaaki
Ueda, Mikio
Arimoto, Taichiro
Uchino, Junji http://orcid.org/0000-0003-0651-7767
Iwasaki, Yoshinobu
Takayama, Koichi
Article History
Received: 8 June 2018
Accepted: 10 August 2018
First Online: 18 August 2018
Compliance with ethical standards
:
: J Uchino reports grants from Eli Lilly Japan K.K., outside the submitted work. T Yamada reports grants from Nippon Boehringer Ingelheim Co., Ltd., and Ono Pharmaceutical Co., Ltd., outside the submitted work. K Takayama reports grants from Chugai-Roche Co., grants from Ono Pharmaceutical Co., personal fees from Astrazeneca Co., personal fees from Chugai-Roche Co., personal fees from MSD-Merck Co., personal fees from Eli Lilly Co., personal fees from Boehringer-Ingelheim Co., personal fees from Daiichi-Sankyo Co., outside the submitted work. The other authors have no conflict of interest to declare.
: All procedures performed in human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Informed consent was obtained from all participants included in the study.